Brief: Lineage Cell Therapeutics Reports Q1 2022 Results
12/05/2022 22:02
May 12 (Reuters) - Lineage Cell Therapeutics Inc LCTX.A :
* LINEAGE CELL THERAPEUTICS REPORTS FIRST QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* QTRLY LOSS PER SHARE $0.04
* Q1 EARNINGS PER SHARE VIEW $-0.03 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw21rZKPa
Further company coverage: LCTX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million